Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 277743011000036118 | Synagis (1 x 50 mg vial, 1 x 1 mL inert diluent ampoule), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 277745011000036117 | Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has container type | pack | true | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | Is a | Synagis (1 x 50 mg vial, 1 x 1 mL inert diluent ampoule), 1 pack | true | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has container type | composite pack | false | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has TPUU | Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | true | Inferred relationship | Some | 1 | |
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has TP | Synagis | true | Inferred relationship | Some | ||
| Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has TPUU | Synagis (inert substance) diluent, 1 mL ampoule | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR